Pure Global
NCT05715385

Comparison of Treatments in Diabetic Macular Edema

Comparison Between Grid Macular Laser and Topical Bromfenac 0.09% in the Treatment of Diabetic Macular Edema
Babasaheb Ambedkar Memorial Hospital·Phase 4·ClinicalTrials.gov·procedureCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetic Macular Edema
Drug/Device/Intervention
laser photocoagulation
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Babasaheb Ambedkar Memorial Hospital
Timeline & enrollment
Phase
Phase 4
Start date
Nov 01, 2014
End date
Oct 01, 2015
Enrollment
60 participants
Primary outcome

Change in visual acuity in laser photocoagulation group,Change in visual acuity in bromfenac group,Change in visual acuity in observation group

Summary

Prospective or cohort study to compare the effects of grid macular laser, topical bromfenac
 0.09% and placebo (carboxymethyl cellulose 0.5%) medication in diabetic macular edema.
 
 60 eyes with macular edema of two types i.e. cystoid macular edema (CME) and clinically
 significant macular edema (CSME) were divided into three groups with 20 patients in each
 group. One group was treated with grid laser photocoagulation, the second group was treated
 with topical bromfenac 0.09% drops two times a day and the third group was treated with
 topical carboxy methyl cellulose 0.5% three times a day (placebo treatment).

ICD-10 classifications
Diabetic retinopathyOther specified diabetes mellitus with ophthalmic complicationsUnspecified diabetes mellitus with ophthalmic complicationsDiabetic cataractType 2 diabetes mellitus with ophthalmic complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05715385
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05715385 through Pure Global AI's free database. This Phase 4 trial is sponsored by Babasaheb Ambedkar Memorial Hospital and is currently Completed. The study focuses on Diabetic Macular Edema. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.